[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
Article
August 1982

Lipid Metabolism in Non-Insulin-Dependent Diabetes Mellitus: Effect of Glipizide Therapy

Author Affiliations

From the Department of Medicine, Stanford University School of Medicine; and Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, Calif.

Arch Intern Med. 1982;142(8):1498-1500. doi:10.1001/archinte.1982.00340210094019
Abstract

• Plasma lipid concentration and lipoprotein composition were studied before and after several months of glipizide treatment in 23 patients with non-insulin-dependent diabetes mellitus. The mean (±SEM) plasma glucose level fell 87 mg/dL, and the fall in plasma glucose concentration was correlated with a reduction in plasma triglyceride, very low-density lipoprotein triglyceride, cholesterol, and low-density lipoprotein cholesterol levels. Furthermore, there was a statistically significant increase in the plasma high-density lipoprotein cholesterol to total cholesterol ratio. Thus, improved diabetic control in patients treated with glipizide with non-insulin-dependent diabetes mellitus leads to changes in lipoprotein metabolism thought to be beneficial in terms of known cardiovascular risk factors.

(Arch Intern Med 1982;142:1498-1500)

×